메뉴 건너뛰기




Volumn 34, Issue 1, 2014, Pages 98-107

Hepatic pathology among patients without known liver disease undergoing bariatric surgery: Observations and a perspective from the Longitudinal Assessment of Bariatric Surgery (LABS) study

(12)  Kleiner, David E a   Berk, Paul D b   Hsu, Jesse Y c   Courcoulas, Anita P d   Flum, David e   Khandelwal, Saurabh e   Pender, John f   Pomp, Alfons g   Roerig, James h   Machado, Laura L i   Wolfe, Bruce M j   Belle, Steven H c  


Author keywords

bariatric surgery; cirrhosis; liver biopsy; NAFLD; steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER;

EID: 84899652361     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0034-1371083     Document Type: Article
Times cited : (42)

References (42)
  • 1
    • 84856487711 scopus 로고    scopus 로고
    • Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010
    • Flegal K. M., Carroll M. D., Kit B. K., Ogden C. L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA: 2012; 307 5 491 497
    • (2012) JAMA , vol.307 , Issue.5 , pp. 491-497
    • Flegal, K.M.1    Carroll, M.D.2    Kit, B.K.3    Ogden, C.L.4
  • 2
    • 0037048669 scopus 로고    scopus 로고
    • Prevalence and trends in obesity among US adults, 1999-2000
    • Flegal K. M., Carroll M. D., Ogden C. L., Johnson C. L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA: 2002; 288 14 1723 1727
    • (2002) JAMA , vol.288 , Issue.14 , pp. 1723-1727
    • Flegal, K.M.1    Carroll, M.D.2    Ogden, C.L.3    Johnson, C.L.4
  • 3
    • 33645523067 scopus 로고    scopus 로고
    • Prevalence of overweight and obesity in the United States, 1999-2004
    • Ogden C. L., Carroll M. D., Curtin L. R., McDowell M. A., Tabak C. J., Flegal K. M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA: 2006; 295 13 1549 1555
    • (2006) JAMA , vol.295 , Issue.13 , pp. 1549-1555
    • Ogden, C.L.1    Carroll, M.D.2    Curtin, L.R.3    McDowell, M.A.4    Tabak, C.J.5    Flegal, K.M.6
  • 4
    • 34247851021 scopus 로고    scopus 로고
    • The Epidemiology of Obesity
    • DOI 10.1053/j.gastro.2007.03.052, PII S0016508507005793
    • Ogden C. L., Yanovski S. Z., Carroll M. D., Flegal K. M. The epidemiology of obesity. Gastroenterology: 2007; 132 6 2087 2102 (Pubitemid 46693751)
    • (2007) Gastroenterology , vol.132 , Issue.6 , pp. 2087-2102
    • Ogden, C.L.1    Yanovski, S.Z.2    Carroll, M.D.3    Flegal, K.M.4
  • 5
    • 33747517955 scopus 로고    scopus 로고
    • The epidemiology of nonalcoholic fatty liver disease in adults
    • DOI 10.1097/01.mcg.0000168638.84840.ff, PII 0000483620060300100003
    • Clark J. M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol: 2006; 40 01 S5 S10 (Pubitemid 44309537)
    • (2006) Journal of Clinical Gastroenterology , vol.40 , Issue.SUPPL. 1
    • Clark, J.M.1
  • 6
    • 79957449923 scopus 로고    scopus 로고
    • Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008
    • Younossi Z. M., Stepanova M., Afendy M., et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol: 2011; 9 6 524 530, e1, quiz e60
    • (2011) Clin Gastroenterol Hepatol , vol.9 , Issue.6 , pp. 524-530
    • Younossi, Z.M.1    Stepanova, M.2    Afendy, M.3
  • 7
    • 84866531658 scopus 로고    scopus 로고
    • Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese
    • Liu C. J. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol: 2012; 27 10 1555 1560
    • (2012) J Gastroenterol Hepatol , vol.27 , Issue.10 , pp. 1555-1560
    • Liu, C.J.1
  • 9
    • 63349106888 scopus 로고    scopus 로고
    • Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network
    • NASH Clinical Research NetworkA list of members of the Nonalcoholic Steatohepatitis Clinical Research Network can be found in the Appendix.
    • Brunt E. M., Kleiner D. E., Wilson L. A., et al. NASH Clinical Research NetworkA list of members of the Nonalcoholic Steatohepatitis Clinical Research Network can be found in the Appendix. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology: 2009; 49 3 809 820
    • (2009) Hepatology , vol.49 , Issue.3 , pp. 809-820
    • Brunt, E.M.1    Kleiner, D.E.2    Wilson, L.A.3
  • 10
    • 26044451626 scopus 로고    scopus 로고
    • Pathological features of NASH
    • Brunt E. M., Tiniakos D. G. Pathological features of NASH. Front Biosci: 2005; 10 1475 1484
    • (2005) Front Biosci , vol.10 , pp. 1475-1484
    • Brunt, E.M.1    Tiniakos, D.G.2
  • 11
    • 84857944399 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: Pathologic patterns and biopsy evaluation in clinical research
    • Kleiner D. E., Brunt E. M. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis: 2012; 32 1 3 13
    • (2012) Semin Liver Dis , vol.32 , Issue.1 , pp. 3-13
    • Kleiner, D.E.1    Brunt, E.M.2
  • 13
    • 78651041767 scopus 로고
    • The liver in obesity
    • Zelman S. The liver in obesity. AMA Arch Intern Med: 1952; 90 2 141 156
    • (1952) AMA Arch Intern Med , vol.90 , Issue.2 , pp. 141-156
    • Zelman, S.1
  • 15
    • 0019152816 scopus 로고
    • Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease
    • Ludwig J., Viggiano T. R., McGill D. B., Oh B. J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc: 1980; 55 7 434 438 (Pubitemid 10057164)
    • (1980) Mayo Clinic Proceedings , vol.55 , Issue.7 , pp. 434-438
    • Ludwig, J.1    Viggiano, T.R.2    McGill, D.B.3    Ott, B.J.4
  • 16
    • 0025178612 scopus 로고
    • The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
    • Powell E. E., Cooksley W. G., Hanson R., Searle J., Halliday J. W., Powell L. W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology: 1990; 11 1 74 80 (Pubitemid 20075105)
    • (1990) Hepatology , vol.11 , Issue.1 , pp. 74-80
    • Powell, E.E.1    Cooksley, W.G.E.2    Hanson, R.3    Searle, J.4    Halliday, J.W.5    Powell, L.W.6
  • 19
    • 84879606466 scopus 로고    scopus 로고
    • New horizons in hepatitis C antiviral therapy with direct-acting antivirals
    • Aghemo A., De Francesco R. New horizons in hepatitis C antiviral therapy with direct-acting antivirals. Hepatology: 2013; 58 1 428 438
    • (2013) Hepatology , vol.58 , Issue.1 , pp. 428-438
    • Aghemo, A.1    De Francesco, R.2
  • 20
    • 84879152382 scopus 로고    scopus 로고
    • A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1
    • Lawitz E., Poordad F., Kowdley K. V., et al. A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1. J Hepatol: 2013; 59 1 18 23
    • (2013) J Hepatol , vol.59 , Issue.1 , pp. 18-23
    • Lawitz, E.1    Poordad, F.2    Kowdley, K.V.3
  • 21
    • 84876582239 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis C: Current and future
    • Pawlotsky J. M. Treatment of chronic hepatitis C: current and future. Curr Top Microbiol Immunol: 2013; 369 321 342
    • (2013) Curr Top Microbiol Immunol , vol.369 , pp. 321-342
    • Pawlotsky, J.M.1
  • 22
    • 84455189494 scopus 로고    scopus 로고
    • The era of direct-acting antivirals has begun: The beginning of the end for HCV
    • Vachon M. L., Dieterich D. T. The era of direct-acting antivirals has begun: the beginning of the end for HCV? Semin Liver Dis: 2011; 31 4 399 409
    • (2011) Semin Liver Dis , vol.31 , Issue.4 , pp. 399-409
    • Vachon, M.L.1    Dieterich, D.T.2
  • 23
    • 2442545703 scopus 로고    scopus 로고
    • Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis and Orthotopic Liver Transplantation
    • DOI 10.1111/j.1600-6143.2004.00432.x
    • Burke A., Lucey M. R. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant: 2004; 4 5 686 693 (Pubitemid 38637564)
    • (2004) American Journal of Transplantation , vol.4 , Issue.5 , pp. 686-693
    • Burke, A.1    Lucey, M.R.2
  • 24
    • 80053581540 scopus 로고    scopus 로고
    • Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
    • Charlton M. R., Burns J. M., Pedersen R. A., Watt K. D., Heimbach J. K., Dierkhising R. A. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology: 2011; 141 4 1249 1253
    • (2011) Gastroenterology , vol.141 , Issue.4 , pp. 1249-1253
    • Charlton, M.R.1    Burns, J.M.2    Pedersen, R.A.3    Watt, K.D.4    Heimbach, J.K.5    Dierkhising, R.A.6
  • 25
    • 77958155198 scopus 로고    scopus 로고
    • Current status and future of liver transplantation
    • Merion R. M. Current status and future of liver transplantation. Semin Liver Dis: 2010; 30 4 411 421
    • (2010) Semin Liver Dis , vol.30 , Issue.4 , pp. 411-421
    • Merion, R.M.1
  • 26
    • 77951874018 scopus 로고    scopus 로고
    • Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
    • Sanyal A. J., Chalasani N., Kowdley K. V., et al. NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med: 2010; 362 18 1675 1685
    • (2010) N Engl J Med , vol.362 , Issue.18 , pp. 1675-1685
    • Sanyal, A.J.1    Chalasani, N.2    Kowdley, K.V.3
  • 27
    • 79953745343 scopus 로고    scopus 로고
    • Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits
    • NASH CRN; GIANT Consortium; MAGIC Investigators; GOLD Consortium.
    • Speliotes E. K., Yerges-Armstrong L. M., Wu J., et al. NASH CRN; GIANT Consortium; MAGIC Investigators; GOLD Consortium. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet: 2011; 7 3 e1001324
    • (2011) PLoS Genet , vol.7 , Issue.3
    • Speliotes, E.K.1    Yerges-Armstrong, L.M.2    Wu, J.3
  • 28
    • 26844483363 scopus 로고    scopus 로고
    • The NIDDK Bariatric Surgery clinical Research Consortium (LABS)
    • LABS Consortium.
    • Belle S., Consortium L.; LABS Consortium. The NIDDK Bariatric Surgery clinical Research Consortium (LABS). Surg Obes Relat Dis: 2005; 1 2 145 147
    • (2005) Surg Obes Relat Dis , vol.1 , Issue.2 , pp. 145-147
    • Belle, S.1    Consortium, L.2
  • 29
    • 0037008087 scopus 로고    scopus 로고
    • Updated definitions of healthy ranges for serum alanine aminotransferase levels
    • Prati D., Taioli E., Zanella A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med: 2002; 137 1 1 10
    • (2002) Ann Intern Med , vol.137 , Issue.1 , pp. 1-10
    • Prati, D.1    Taioli, E.2    Zanella, A.3
  • 31
    • 68049123594 scopus 로고    scopus 로고
    • Perioperative safety in the longitudinal assessment of bariatric surgery
    • Longitudinal Assessment of Bariatric Surgery (LABS) Consortium.
    • Flum D. R., Belle S. H., King W. C., et al. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med: 2009; 361 5 445 454
    • (2009) N Engl J Med , vol.361 , Issue.5 , pp. 445-454
    • Flum, D.R.1    Belle, S.H.2    King, W.C.3
  • 32
    • 84890433324 scopus 로고    scopus 로고
    • Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study
    • LABS Consortium. [Epub ahead of print]
    • Belle S. H., Berk P. D., Chapman W. H., et al. LABS Consortium. Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. Surg Obes Relat Dis: 2013; 9 6 926 935 [Epub ahead of print]
    • (2013) Surg Obes Relat Dis , vol.9 , Issue.6 , pp. 926-935
    • Belle, S.H.1    Berk, P.D.2    Chapman, W.H.3
  • 33
    • 0029039362 scopus 로고
    • Histological grading and staging of chronic hepatitis
    • Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol: 1995; 22 6 696 699
    • (1995) J Hepatol , vol.22 , Issue.6 , pp. 696-699
    • Ishak, K.1    Baptista, A.2    Bianchi, L.3
  • 34
    • 84868235041 scopus 로고    scopus 로고
    • Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
    • Bedossa P., Poitou C., Veyrie N., et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology: 2012; 56 5 1751 1759
    • (2012) Hepatology , vol.56 , Issue.5 , pp. 1751-1759
    • Bedossa, P.1    Poitou, C.2    Veyrie, N.3
  • 35
  • 36
    • 24144481800 scopus 로고    scopus 로고
    • Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women
    • DOI 10.1002/hep.20818
    • Kunde S. S., Lazenby A. J., Clements R. H., Abrams G. A. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology: 2005; 42 3 650 656 (Pubitemid 41233658)
    • (2005) Hepatology , vol.42 , Issue.3 , pp. 650-656
    • Kunde, S.S.1    Lazenby, A.J.2    Clements, R.H.3    Abrams, G.A.4
  • 38
    • 84861543083 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    • Chalasani N., Younossi Z., Lavine J. E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology: 2012; 55 6 2005 2023
    • (2012) Hepatology , vol.55 , Issue.6 , pp. 2005-2023
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3
  • 39
    • 67349271289 scopus 로고    scopus 로고
    • Alrfeti Does Liver Appearance Predict Histopathologic Findings E., Analysis Of Routine Liver Biopsies During Bariatric Surgery P.
    • Dolce C. J., Russo M., Keller J. E., et al. Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. Surg Obes Relat Dis: 2009; 5 3 323 328
    • (2009) Surg Obes Relat Dis , vol.5 , Issue.3 , pp. 323-328
    • Dolce, C.J.1    Russo, M.2    Keller, J.E.3
  • 41
    • 41549129499 scopus 로고    scopus 로고
    • Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels
    • DOI 10.1001/archinternmed.2007.131
    • Neuschwander-Tetri B. A., Unalp A., Creer M. H.; Nonalcoholic Steatohepatitis Clinical Research Network. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. Arch Intern Med: 2008; 168 6 663 666 (Pubitemid 351468402)
    • (2008) Archives of Internal Medicine , vol.168 , Issue.6 , pp. 663-666
    • Neuschwander-Tetri, B.A.1    Unalp, A.2    Creer, M.H.3
  • 42
    • 56649115813 scopus 로고    scopus 로고
    • Role of fatty acids in the pathogenesis of obesity and fatty liver: Impact of bariatric surgery
    • Verna E. C., Berk P. D. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis: 2008; 28 4 407 426 Diseases
    • (2008) Semin Liver Dis , vol.28 , Issue.4 , pp. 407-426
    • Verna, E.C.1    Berk, P.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.